Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company known for its cystic fibrosis (CF) treatments, is at a critical juncture as it seeks to diversify its portfolio and maintain its ...

Inc., the parent company of Google, stands at a critical juncture as it navigates a complex landscape of technological innovation, regulatory challenges, and market competition. With a market ...

Palantir Technologies Inc.’s hefty premium will be in focus when the data analysis software giant reports earnings after the ...

Merion Road Capital Management, an investment advisor, released its fourth-quarter 2024 investor letter. A copy of the letter ...

In a report released on January 31, Daniel Perlin from RBC Capital maintained a Buy rating on Broadridge Financial Solutions (BR – Research ...

This may lead to greater sales of Nvidia's latest GPUs as they can maximize inferencing performance. The company's new ...

In a significant cyberattack, Tata Technologies, a prominent Indian multinational engineering and design services company, ...

SoftBank's investment in OpenAI may position the company as the world's joint-second most valuable private tech firm after ...

Although the company's Q1 2025 earnings call saw a double beat, analysts remain divided on the future prospects of Apple ...

Dow, S&P 500, and Nasdaq futures are rising in premarket trading Friday as the stock market waits for news on President Donald Trump's threats to apply tariffs on Mexico, Canada, and China. Also PCE ...

SK Hynix's shares slumped, hit by the shock from Chinese artificial-intelligence startup DeepSeek as stock trading resumed in South Korea after a four-day holiday.

Asia markets are mostly higher following gains on Wall Street driven by Tesla, IBM and Meta Platforms after strong profit reports ...